Novavax COVID-19 Vaccine Could Get EU Approval ‘In Weeks’
Having completed a rolling review, the vaccine is now being evaluated by the European Medicines Agency for conditional marketing authorization under an accelerated timeline.
You may also be interested in...
EU Approval In View For Novavax COVID-19 Vaccine; EMA OKs Janssen Booster
It’s all go on the EU coronavirus front this week: three new therapies and another vaccine booster have been recommended for use, and a special session on the Novavax vaccine is to be held at the EMA next week. More production capacity has been OKd for three vaccines.
Omicron Clouds Novavax’s Delayed COVID-19 Vaccine Debut
Novavax has already gained its first emergency use authorization for its COVID-19 vaccine, but doubts remain about its manufacturing and Omicron readiness.
Seventeen And Counting – Bumper Crop Of New EU Filings
Orphan drugs and COVID-19 products are among the latest filings under review by the European Medicines Agency for potential pan-EU approval.